Table 1.
Ref. | No. Isolates † | Strain Origin | Ribotype | ST Type | Other | Gene (Mutation, If Known) | VAN MIC (mg/L) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
vanG/vanSR | vanA | vanB | vanW | vanZ | murG | rpoC | |||||||
[22] | 4 | Clinical | 012 | 54 | NAPCR1 | vanG | 4 | ||||||
[23] * | 1 | Laboratory | 027 | 1 | WS2/ R20291 |
vanS (Arg314Leu) | 8 | ||||||
1 | Laboratory | 027 | 1 | WS4/ R20291 | vanS (Gly319Asp) | 16 | |||||||
1 | Clinical | 027 | 1 | MT1470 | vanS (Ser313Phe) | 8 | |||||||
1 | Clinical | 027 | 1 | MT5006 | vanS (Thr349Ile) | 8 | |||||||
9 | Clinical | 027 | 1 | see note ‡ | vanR (Thr115Ala) | 4–8 ‡ | |||||||
[24] | 1 | Clinical | 35 | vanA | vanW | 4 | |||||||
1 | Clinical | 014-020 | 2 | vanB | 8 | ||||||||
1 | Clinical | 42 | vanB | 4 | |||||||||
1 | Clinical | 67 | vanB | vanW | >16 | ||||||||
1 | Clinical | 012 | 54 | vanW | vanZ | 4 | |||||||
[25] * | 1 | Laboratory | 087 | NB95013/ATCC 43255 | murG/cd2725 (Pro108Leu) | 16 | |||||||
1 | Laboratory | NB95026 | rpoC/cd0067 (Gly733Thr) | 16 |
Abbv: Ref., reference; no., number; ST, multilocus sequence type; MIC, minimum inhibitory concentration; VAN, vancomycin. Notes:* These studies utilized serial passaging and selection for mutants with decreased susceptibility. † Number of isolates expressing resistance, defined as vancomycin MIC > 2 mg/L [4,5]. ‡ 7 isolates from the Texas Medical Center had MICs = 4 mg/L and 2 isolates from Israel had MICs = 8 mg/L